CA2271652A1 - Compact member comprising a plurality of porous cellulose matrices, (pcms), method of manufacturing and use thereof - Google Patents
Compact member comprising a plurality of porous cellulose matrices, (pcms), method of manufacturing and use thereof Download PDFInfo
- Publication number
- CA2271652A1 CA2271652A1 CA002271652A CA2271652A CA2271652A1 CA 2271652 A1 CA2271652 A1 CA 2271652A1 CA 002271652 A CA002271652 A CA 002271652A CA 2271652 A CA2271652 A CA 2271652A CA 2271652 A1 CA2271652 A1 CA 2271652A1
- Authority
- CA
- Canada
- Prior art keywords
- release
- pcms
- compact member
- active compound
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9604124-9 | 1996-11-12 | ||
SE9604124A SE9604124D0 (sv) | 1996-11-12 | 1996-11-12 | Compact member, method of manufacturing and use thereof |
US3172396P | 1996-11-25 | 1996-11-25 | |
US60/031,723 | 1996-11-25 | ||
PCT/SE1997/001901 WO1998020858A1 (en) | 1996-11-12 | 1997-11-12 | COMPACT MEMBER COMPRISING A PLURALITY OF POROUS CELLULOSE MATRICES, (PCMs), METHOD OF MANUFACTURING AND USE THEREOF |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2271652A1 true CA2271652A1 (en) | 1998-05-22 |
Family
ID=26662794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002271652A Abandoned CA2271652A1 (en) | 1996-11-12 | 1997-11-12 | Compact member comprising a plurality of porous cellulose matrices, (pcms), method of manufacturing and use thereof |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0941069A1 (de) |
JP (1) | JP2001503766A (de) |
AU (1) | AU728754B2 (de) |
CA (1) | CA2271652A1 (de) |
NZ (1) | NZ335737A (de) |
WO (1) | WO1998020858A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2360655C (en) * | 1999-01-29 | 2007-03-20 | Losan Pharma Gmbh | Pharmaceutical compositions |
DE60021570T2 (de) * | 1999-06-07 | 2006-05-24 | Altana Pharma Ag | Neue zubereitung und darreichungsform enthaltend einen säurelabilen protonenpumpeninhibitor |
GB0123400D0 (en) | 2001-09-28 | 2001-11-21 | Novartis Ag | Organic compounds |
US7001475B2 (en) | 2001-12-11 | 2006-02-21 | 3M Innovative Properties Company | Film structures and methods of making film structures |
MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
US20040109889A1 (en) | 2002-12-04 | 2004-06-10 | Bunick Frank J. | Surface treatment composition for soft substrates |
DE102005028696A1 (de) * | 2005-06-21 | 2006-12-28 | Pulmotec Gmbh | Verwendung eines Hilfsstoffs zur Einstellung der Abrasionsfestigkeit eines verfestigten Wirkstoffpräparats |
EP2191848A4 (de) * | 2007-08-31 | 2013-05-15 | Daiichi Sankyo Co Ltd | Zubereitung mit verzögerter freisetzung und herstellungsverfahren dafür |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9002017D0 (sv) * | 1990-06-06 | 1990-06-06 | Kabivitrum Ab | Process for manufacture of matrices |
DE69114006T2 (de) * | 1990-06-20 | 1996-05-02 | Advanced Polymer Systems Inc | Zusammensetzungen und verfahren für die kontrollierte freisetzung von löslichen wirkstoffen. |
SE9301220D0 (sv) * | 1993-04-14 | 1993-04-14 | Kabi Pharmacia Ab | Manufacturing matrices |
-
1997
- 1997-11-12 WO PCT/SE1997/001901 patent/WO1998020858A1/en not_active Application Discontinuation
- 1997-11-12 AU AU50758/98A patent/AU728754B2/en not_active Ceased
- 1997-11-12 CA CA002271652A patent/CA2271652A1/en not_active Abandoned
- 1997-11-12 JP JP52247998A patent/JP2001503766A/ja not_active Withdrawn
- 1997-11-12 NZ NZ335737A patent/NZ335737A/xx unknown
- 1997-11-12 EP EP97913618A patent/EP0941069A1/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU5075898A (en) | 1998-06-03 |
AU728754B2 (en) | 2001-01-18 |
WO1998020858A1 (en) | 1998-05-22 |
JP2001503766A (ja) | 2001-03-21 |
NZ335737A (en) | 2000-09-29 |
EP0941069A1 (de) | 1999-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4748023A (en) | Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content | |
US4708874A (en) | Devices for the controlled release of active substances, as well as process for the preparation thereof | |
Hilton et al. | In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxycillin trihydrate | |
CA1201064A (en) | Constant release rate solid oral dosage formulations of drugs having a pk.sub.a7-10 and an aqueous solubility of 15-100 g/ml water | |
JP5170723B2 (ja) | 活性薬剤の制御放出用錠剤 | |
JPS63258407A (ja) | 徐放性カプセル | |
US8703203B2 (en) | Oral dosage form of deferasirox | |
WO1998009597A2 (en) | Cushioning beads and tablet comprising the same capable of forming a suspension | |
HRP980379A2 (en) | Sertraline salts and sustained-release dosage forms of sertraline | |
JP2008510000A (ja) | 制御放出性ナノ粒子有効薬剤配合物投与剤型品および方法 | |
US7364755B2 (en) | Modified calcium phosphate excipient | |
DE19931708A1 (de) | Verfahren zur Herstellung schnell zerfallender, fester pharmazeutischer Zubereitungen | |
US20130039982A1 (en) | Low-dose tablets and preparation process | |
AU728754B2 (en) | Compact member comprising a plurality of porous cellulose matrices, (PCMs), method of manufacturing and use thereof | |
US6322813B1 (en) | Compact member, method of manufacturing and use thereof | |
Danckwerts | Development of a zero-order release oral compressed tablet with potential for commercial tabletting production | |
Shotton et al. | Effect of intragranular and extragranular disintegrating agents on particle size of disintegrated tablets | |
Malamataris et al. | Sustained release from matrix system comprising hydrophobia and hydrophilic (gel-forming) parts | |
JP2001335469A (ja) | 固体製剤の製造方法 | |
Bredenberg | New Concepts in Administration of Drugs in Tablet Form: Formulation and Evaluation of a Sublingual Tablet for Rapid Absorption, and Presentation of an Individualised Dose Administration System | |
KR0137270B1 (ko) | 트리메부틴의 서방형 조성물 및 그 제조 방법 | |
KR950007097B1 (ko) | 서방성 캡슐 | |
Bashaiwoldu | Studies on the influence of composition and processing on the mechanical properties of pellets and compacted pellets | |
Louw | Evaluation and comparison of magnesium stearate and sodium stearyl fumarate (Pruv) as lubricants in directly compressible tablet formulations: their effect on tablet properties and drug dissolution | |
Mohammed et al. | Effect of a co-processed excipient on the disintegration and drug release profile of ibuprofen tablets |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |